Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma.

Erin EM, Leaker BR, Nicholson GC, Tan AJ, Green LM, Neighbour H, Zacharasiewicz AS, Turner J, Barnathan ES, Kon OM, Barnes PJ, Hansel TT.

Am J Respir Crit Care Med. 2006 Oct 1;174(7):753-62. Epub 2006 Jul 13. Retraction in: Am J Respir Crit Care Med. 2011 Feb 1;183(3):418.

PMID:
16840747
2.

Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.

Boonsawat W, Goryachkina L, Jacques L, Frith L.

Clin Drug Investig. 2008;28(2):101-11.

PMID:
18211118
4.

First study of infliximab treatment in patients with chronic obstructive pulmonary disease.

van der Vaart H, Koëter GH, Postma DS, Kauffman HF, ten Hacken NH.

Am J Respir Crit Care Med. 2005 Aug 15;172(4):465-9. Epub 2005 Jun 3.

PMID:
15937294
5.

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.

Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.

Clin Ther. 2008 Aug;30(8):1492-504. doi: 10.1016/j.clinthera.2008.07.018.

PMID:
18803991
6.
7.

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.

Taylor DR, Sears MR, Herbison GP, Flannery EM, Print CG, Lake DC, Yates DM, Lucas MK, Li Q.

Thorax. 1993 Feb;48(2):134-8.

8.

A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.

Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L, Robinson D, Wenzel S, Busse W, Hansel TT, Barnes NC; International Mepolizumab Study Group..

Am J Respir Crit Care Med. 2007 Dec 1;176(11):1062-71. Epub 2007 Sep 13.

PMID:
17872493
9.

Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).

Gappa M, Zachgo W, von Berg A, Kamin W, Stern-Sträter C, Steinkamp G; VIAPAED Study Group..

Pediatr Pulmonol. 2009 Nov;44(11):1132-42. doi: 10.1002/ppul.21120.

PMID:
19824054
10.

Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

Milgrom H, Fick RB Jr, Su JQ, Reimann JD, Bush RK, Watrous ML, Metzger WJ.

N Engl J Med. 1999 Dec 23;341(26):1966-73.

11.

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.

Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM.

N Engl J Med. 2009 Mar 5;360(10):985-93. doi: 10.1056/NEJMoa0805435.

12.
13.

Early use of inhaled nedocromil sodium in children following an acute episode of asthma.

Edwards AM, Lyons J, Weinberg E, Weinberg F, Gillies JD, Reid G, Robertson CF, Robinson P, Dalton M, Van Asperen P, Wilson C, Mullineux J, Mullineux A, Sly PD, Cox M, Isles AF.

Thorax. 1999 Apr;54(4):308-15.

14.

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.

Rennard SI, Fogarty C, Kelsen S, Long W, Ramsdell J, Allison J, Mahler D, Saadeh C, Siler T, Snell P, Korenblat P, Smith W, Kaye M, Mandel M, Andrews C, Prabhu R, Donohue JF, Watt R, Lo KH, Schlenker-Herceg R, Barnathan ES, Murray J; COPD Investigators..

Am J Respir Crit Care Med. 2007 May 1;175(9):926-34. Epub 2007 Feb 8.

PMID:
17290043
15.

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K.

Allergy. 2005 Mar;60(3):309-16.

16.

The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma.

Heinig JH, Boulet LP, Croonenborghs L, Möllers MJ.

Respir Med. 1999 Sep;93(9):613-20.

PMID:
10542974
17.

Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.

Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM.

J Allergy Clin Immunol. 2011 Aug;128(2):315-22. doi: 10.1016/j.jaci.2011.06.004.

PMID:
21807250
18.

Analysis of induced sputum before and after withdrawal of treatment with inhaled corticosteroids in asthmatic patients.

Giannini D, Di Franco A, Cianchetti S, Bacci E, Dente FL, Vagaggini B, Paggiaro PL.

Clin Exp Allergy. 2000 Dec;30(12):1777-84.

PMID:
11122217
19.
20.

The inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled corticosteroid dose in asthmatic patients.

Löwhagen O, Wever AM, Lusuardi M, Moscato G, De Backer WA, Gandola L, Donner CF, Ahlstedt S, Larsson L, Holgate ST.

Respir Med. 2002 Feb;96(2):95-101.

PMID:
11862965

Supplemental Content

Support Center